Cosentyx sensoready 150 MG penml
Ended Awarded Last action
- Contract number
- SPE2DR26F8D9R
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,687
Award facts
- Contract value 100% obligated
- $15,687.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $15,687.28 for Cosentyx Sensoready 150 mg pen/ml on December 9, 2025, with completion scheduled for December 10, 2025. This firm fixed-price contract represents a non-competitive delivery order issued under a larger vehicle and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Cosentyx is a biologic immunosuppressant medication used to treat autoimmune conditions including psoriasis, psoriatic arthritis, and ankylosing spondylitis, making this a critical pharmaceutical supply for military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical prime vendor contract extending through December 2026. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement across multiple therapeutic domains, supplying brand-name and generic medications, vaccines, and specialized medical supplies to support Defense Health Agency operations and other federal healthcare systems worldwide. The company's extensive federal contract portfolio demonstrates its capability to meet complex pharmaceutical supply requirements for military healthcare programs.
Quick answers
Who was awarded contract SPE2DR26F8D9R?
SPE2DR26F8D9R was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26F8D9R worth?
The government has obligated $15,687 on SPE2DR26F8D9R.
Is contract SPE2DR26F8D9R an order under another contract?
Yes. SPE2DR26F8D9R is a delivery order under SPE2DR25D3202, an indefinite delivery contract.
Was contract SPE2DR26F8D9R competed?
The extent of competition for SPE2DR26F8D9R was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award